GSDMD knockdown attenuates phagocytic activity of microglia and exacerbates seizure susceptibility in TLE mice

Xiaoxia Yang1, Qingqing Cao2, Yi Guo3

  • 1Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Anshan Road No. 154, Tianjin, 300052, China.

PubMed
Abstract

Insights

Gasdermin D (GSDMD) knockdown worsens temporal lobe epilepsy (TLE) by reducing microglial phagocytosis of apoptotic neurons. Enhancing microglial activity protects against seizures in TLE models.

Area of Science:

  • Neuroscience
  • Immunology
  • Epilepsy Research

Background:

  • Temporal lobe epilepsy (TLE) is characterized by hippocampal neuronal loss.
  • Microglial phagocytosis clears apoptotic debris, aiding repair.
  • Gasdermin D (GSDMD)-mediated pyroptosis is implicated in TLE pathogenesis.

Purpose of the Study:

  • To investigate the role of GSDMD-mediated pyroptosis in microglial phagocytosis.
  • To determine the impact of GSDMD on apoptotic neuron accumulation in TLE.
  • To explore GSDMD's influence on the overall pathogenesis of TLE.

Main Methods:

  • A kainic acid (KA) model of TLE was established in mice.
  • Seizure severity was assessed using Racine scores and local field potential (LFP) recordings.
  • Neuronal death, microglial morphology, and phagocytic activity were evaluated using Nissl, TUNEL, and immunofluorescence staining, with validation using lipopolysaccharide (LPS) and P2Y12R agonist 2MeSADP.

Main Results:

  • GSDMD knockdown increased apoptotic neuron accumulation and seizure susceptibility in TLE mice.
  • Microglia exhibited M1 polarization with elevated pro-inflammatory cytokines upon GSDMD knockdown, alongside reduced migration and phagocytosis.
  • LPS-activated microglia and 2MeSADP treatment attenuated TLE severity by enhancing microglial phagocytic activity.

Conclusions:

  • GSDMD knockdown exacerbates TLE by impairing microglial phagocytosis of apoptotic neurons.
  • GSDMD appears to play a protective role in KA-induced TLE.
  • Targeting microglial phagocytic activity may offer therapeutic potential for TLE.

Related Concept Videos